XML 40 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Net product revenue $ 6,001 $ 1,110 $ 0
Licensing revenue 25,000 0 0
Royalties and other revenue 80 94 139
Total revenues 31,081 1,204 139
Operating expenses:      
Cost of sales 616 85 0
Research and development 84,480 58,887 52,816
Selling, General and Administrative Expense 143,102 113,982 48,083
Total operating expenses 228,198 172,954 100,899
Loss from operations (197,117) (171,750) (100,760)
Interest and other expense (15,579) (13,101) (2,780)
Interest income and other, net 12,293 7,732 1,596
Net loss $ (200,403) $ (177,119) $ (101,944)
Net loss per common share, basic (usd per share) $ (0.63) $ (0.80) $ (0.62)
Net loss per common share, diluted (usd per share) $ (0.63) $ (0.80) $ (0.62)
Shares used in computing net loss per common share, basic 320,031 221,130 165,733
Shares used in computing net loss per common share, diluted 320,031 221,130 165,733
Other comprehensive loss:      
Unrealized gain (loss) on investments $ 88 $ 459 $ (418)
Comprehensive loss $ (200,315) $ (176,660) $ (102,362)